全文获取类型
收费全文 | 16848篇 |
免费 | 1002篇 |
国内免费 | 438篇 |
专业分类
耳鼻咽喉 | 59篇 |
儿科学 | 861篇 |
妇产科学 | 245篇 |
基础医学 | 3283篇 |
口腔科学 | 251篇 |
临床医学 | 1247篇 |
内科学 | 3363篇 |
皮肤病学 | 308篇 |
神经病学 | 1309篇 |
特种医学 | 304篇 |
外国民族医学 | 1篇 |
外科学 | 1296篇 |
综合类 | 1428篇 |
预防医学 | 882篇 |
眼科学 | 288篇 |
药学 | 1857篇 |
2篇 | |
中国医学 | 411篇 |
肿瘤学 | 893篇 |
出版年
2023年 | 239篇 |
2022年 | 394篇 |
2021年 | 508篇 |
2020年 | 440篇 |
2019年 | 744篇 |
2018年 | 779篇 |
2017年 | 515篇 |
2016年 | 418篇 |
2015年 | 476篇 |
2014年 | 792篇 |
2013年 | 911篇 |
2012年 | 673篇 |
2011年 | 824篇 |
2010年 | 659篇 |
2009年 | 603篇 |
2008年 | 687篇 |
2007年 | 604篇 |
2006年 | 553篇 |
2005年 | 561篇 |
2004年 | 484篇 |
2003年 | 430篇 |
2002年 | 379篇 |
2001年 | 307篇 |
2000年 | 284篇 |
1999年 | 338篇 |
1998年 | 296篇 |
1997年 | 248篇 |
1996年 | 191篇 |
1995年 | 200篇 |
1994年 | 157篇 |
1993年 | 153篇 |
1992年 | 125篇 |
1991年 | 103篇 |
1990年 | 79篇 |
1989年 | 63篇 |
1988年 | 48篇 |
1987年 | 65篇 |
1985年 | 321篇 |
1984年 | 381篇 |
1983年 | 285篇 |
1982年 | 295篇 |
1981年 | 299篇 |
1980年 | 276篇 |
1979年 | 243篇 |
1978年 | 180篇 |
1977年 | 119篇 |
1976年 | 172篇 |
1975年 | 117篇 |
1974年 | 113篇 |
1973年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study 总被引:1,自引:1,他引:0
E. Farbu T. Rekand E. Vik-Mo H. Lygren N. E. Gilhus J. A. Aarli 《European journal of neurology》2007,14(1):60-65
Post-polio syndrome (PPS) is characterized by new muscle weakness, atrophy, fatigue and pain developing several years after the acute polio. Some studies suggest an ongoing inflammation in the spinal cord in these patients. From this perspective, intravenous immunoglobulin (IvIg) could be a therapeutic option. We performed a double-blinded randomized controlled pilot study with 20 patients to investigate the possible clinical effects of IvIg in PPS. Twenty patients were randomized to either IvIg 2 g/kg body weight or placebo. Primary endpoints were changes in pain, fatigue and muscle strength 3 months after treatment. Surrogate endpoints were changes in cerebrospinal fluid (CSF) cytokine levels. Secondary endpoints were pain, fatigue and isometric muscle strength after 6 months. Patients receiving IvIg reported a significant improvement in pain during the first 3 months, but no change was noted for subjective fatigue and muscle strength. CSF levels of tumour necrosis factor- α (TNF- α ) were increased compared with patients with non-inflammatory neurological disorders. In conclusion, in this small pilot study no effect was seen with IvIg treatment on muscle strength and fatigue, however IvIg treated PPS patients reported significantly less pain 3 months after treatment. TNF- α was increased in the CSF from PPS patients. The results are promising, but not conclusive because of the low number of patients studied. 相似文献
32.
J. R. Buscombe I. Khalkhali G. R. Mason D. Rauh J. Meatherall W. J. G. Oyen F. H. M. Corstens 《European journal of nuclear medicine and molecular imaging》1994,21(10):1148-1150
Functional imaging is ideally suited to monitoring the effect of specific therapy on disease processes. In this pilot study five patients with AIDS and Pneumocystis carinii pneumonia (PCP) were imaged with Indium-111 labelled pooled human immunoglobulin (111In-HIG) during infection and after therapy for PCP. The lung activity of t t tln-HIG, measured as a lung/heart ratio, was calculated in a study performed during infection with PCP and after therapy. In all five patients the lung/heart ratio of t t 1ln-HIG was reduced after treatment. The mean reduction in heart/lung ratio was 27% (range 12%-53%). If these results are confirmed by a larger study, 11In-HIG will be useful in monitoring the response of PCP to therapy in patients with AIDS. 相似文献
33.
Michael R. Perkin David P. Strachan Hywel C. Williams Cameron T. C. Kennedy Jean Golding the ALSPAC Study Team 《Pediatric allergy and immunology》2004,15(3):221-229
We investigated the natural history of atopic dermatitis (AD) in a population-based birth cohort and assessed whether children at risk of visible eczema at 5 years of age can be identified from total immunoglobulin E (IgE) levels measured at 8, 12 and 18 months. AD data collected included a whole body examination for visible eczema at 49 months (4 years) and 61 months (5 years) of age and parent completed questionnaire data throughout their early lives. Children were divided into four groups based on their natural history of early AD: persistent (AD at 1, 6, 18, 30 and 42 months, n = 34), intermittent early onset (before 18 months of age, n = 495), intermittent late onset (18–42 months of age, n = 273) and unaffected ( n = 429). Visible eczema at 5 years of age was present in 12.2% (117/957) (95% confidence interval [CI] 10.1–14.3%) of the children. Levels of total IgE at 8, 12 and 18 months of age were associated with early onset of AD, but not with AD of later onset. For all four natural history groups, the geometric mean total IgE at 12 months was higher in those who subsequently had visible eczema than those who did not. However, the degree of overlap was such that total IgE at 12 months of age was a poor predictor of eczema at age five. A cutoff point of 78 kU/l had the highest positive predictive value for visible eczema at 5 years of age of 28.6%, with a sensitivity of 12% and specificity of 95%. 相似文献
34.
目的 研究慢性乙型肝炎患者PBMC和活检肝组织的APOBEC3G(A3G)mRNA表达状况并探讨两者之间的相关性;研究A3G mRNA转录表达水平与血清HBV DNA、ALT、PT水平及乙型肝炎肝组织学活动度Knodell计分的相关性.方法 采用实时荧光相对定苗RT-PCR的方法 检测45例慢性乙型肝炎患者PBMC及肝组织中A3G mRNA的表达水平,同时采用实时荧光定量PCR方法 检测血清HBV DNA;常规检测TBil、ALT、PT及乙型肝炎肝组织学活动度Knodell计分.同时设15例健康体检者为阴性对照组.结果 ①慢性乙型肝炎患者PBMC、肝组织均表达A3G mRNA.PBMC A3G mRNA表达水平与活检肝组织A3G mRNA表达呈正相关(r=0.457,P<0.05);②PBMC A3G mRNA与肝组织炎症活动度呈负相关(r=-0.441,P<0.05);③PBMC A3G表达水平与HBV DNA呈正相关(r=0.299,P<0.05),与TBil、ALT、PT无相关性.结论 本组研究显示:①体内研究慢性乙型肝炎患者A3G mRNA抗HBV作用,可首选外周血作为临床适用样本.②慢性乙型肝炎患者PBMC A3G mRNA水平可预测其肝组织损害程度,PBMC A3G mRNA水平越高,肝组织损害越轻. 相似文献
35.
目的:观察大剂量静脉滴注免疫球蛋白(HD-IVIG)治疗重型格林-巴利综合征(GBS)的疗效.方法:选择确诊为重型GBS的病例13例,于首次发病后2周内给予HD-IVIG治疗,剂量为0.4g*kg-1*d-1,连续5天为一疗程.治疗前后采用神经功能缺损评分法进行疗效评价.结果:13例GBS患者治疗前后神经功能缺损评分分别为4.23±0.44与2.54±1.45,治疗后比治疗前降低1.69±1.18,差异有显著性(P<0.01),同时治疗前后有很高的相关性(P<0.01).结论:HD-IVIG 治疗重型GBS疗效出现早,人工辅助通气时间短,可作为治疗重型GBS的首选方法. 相似文献
36.
目的 探讨军人花粉症治疗的有效方法。方法 采用提高起始浓度和快速递增浓度 ,上臂外侧皮下注射的方法对 10 6位军人花粉症患者行快速免疫治疗 ,并对每一位患者治疗前后检测血清中总IgE和嗜酸细胞阳离子蛋白 (ECP)。 结果 治疗前后患者总IgE和ECP值有显著性差异。 10 6例患者经 1~ 3年随访复查 ,78例 2个以上发病季节未发作 ,或仅有轻微鼻痒、眼痒 ,18例症状减轻 ,发病时间缩短半月 ,10例症状无明显改善。显效 82例 ,有效 14例 ,无效 10例 ,总有效率为 90 .5 7%。结论 快速免疫治疗能使患者血清总IgE和ECP下降 ,对军人花粉症疗效好。 相似文献
37.
38.
In enamel fluorosis model rats treated with sodium fluoride, secretory ameloblasts of incisor tooth germs exhibited disruption
of intracellular trafficking. We examined whether heterotrimeric G proteins participated in the disruption of vesicular trafficking
of the secretory ameloblast exposed to fluoride, using immunoblotting and pertussis toxin (IAP)-induced adenosyl diphosphate
(ADP)-ribosylation for membrane fractions of the cell. Immunoblotting of crude membranes, post supernatants of the ameloblast,
with anti-Gi3/o and anti-Gs antibodies showed that Gi3 or Go proteins existed in the secretory ameloblast, but Gs protein did not. Immunoblotting of the subcellular membrane fractions indicated that the Gi3 or Go proteins were located in the Golgi membrane, but were not in the rough endoplasmic reticulum (rER) membrane. Autoradiograph
of IAP-induced ADP-ribosylation, however, showed the existence of IAP-sensitive G proteins both in rER and Golgi membranes.
Fluoride treatment decreased the G proteins bound to both membranes. These findings indicate that different G proteins, both
of which are IAP-sensitive, are present in the rER and Golgi apparatus, and suggest that these G proteins participate in the
disturbance of intracellular transport of the secretory ameloblast exposed to fluoride.
Received: 24 June 1998 / Accepted: 8 September 1998 相似文献
39.
Carmelo Romano Michael A. Sesma Colin T. McDonald Karen O'malley Anthony N. van den Pol John W. Olney 《The Journal of comparative neurology》1995,355(3):455-469
The receptor mGluR5 is a metabotropic glutamate receptor with messenger RNA abundantly present throughout cortex, hippocampus, and caudate/putamen that is also coupled to phosphatidyl inositide hydrolysis and calcium mobilization. In this study, the distribution of mGluR5 was examined in rat brain by immunocytochemistry. The antibody utilized is highly specific and does not cross react with the most closely related other metabotropic glutamate receptor, as determined by Western blot analysis of nonneuronal cells transfected with metabotropic receptor coding sequences. The receptor mGluR5 is widely expressed with the highest density in olfactory bulb, caudate/putamen, lateral septum, cortex, and hippocampus, as confirmed with both immunocytochemistry and Western blot analysis. Electron microscopic studies in hippocampus and cortex indicate that the labeling is mostly on membranes of dendritic spines and shafts. Light and electron microscopic evidence indicates that some mGluR5 immunoreactivity is located in presynaptic axon terminals, suggesting that mGluR5 may function as a presynaptic receptor. 相似文献
40.